Description: Notes on the IAA meeting that took place in D.C. in May

Description: Interview of new Section Council members for 2022-2023 year.

Description: As the size of the life reinsurance market in Bermuda has grown to over half a trillion dollars at the end of 2021, more and more actuaries are getting involved with this 21 square mile North Atlantic island in one way or the other. Come explore a fundamental understanding of the Bermuda solvency framework and an overview of its upcoming changes.

Description: "On the decomposition of mortality models into causes of death – Andrés M Villegas Ph.D – UNSW Australia, Madhavi Bajekal, Ph.D.,HONFIA, University of London, UK, Steven Haberman, Ph.D. – Bayes Business School, University of London, UK Forecasting cause-specific mortality rates using the insights from the cointegration analysis, Séverine Arnold, PhD, Viktoriya Glushko, Department of Actuarial Science, Faculty of Business and Economics (HEC Lausanne), University of Lausanne, Switzerland"

Description: This article presents a summary of ideas discussed in a 1999 symposium on the subject of the pros and cons of privatization as an element of the U.S. Social Security system. The four main topics addressed were: 1. Overview of Social Security reform. 2. Pros and cons of privatization. 3. Impact of privatization. 4. Practical issues of privatization. From: The Actuary, September 1999 – volume 33 - Issue 7.

Description: Explore the value and cost of prescription drugs, how they should be defined and measured and the effects various stakeholders in the pharmacy ecosystem can have on these factors in the latest webcast. You'll investigate the impact of coverage, formulary and rebate negotiations and related benefit design. Find out how actuaries can answer questions related to the prescription drug industry, in addition to improving the access, quality and affordability of prescription drugs in the United States. Join us for this webcast and come learn about value-based contract design, negotiations, implementation and administration for prescription drugs.

Description: Discussion of the diversification activities of a number of life insurance companies. This includes the formation of, or acquisition of, property and casualty insurers, variable annuity companies, mutual fund management companies, banks, finance companies, leasing companies, real estate development companies, televisions and radio stations, newspapers, software consultants and other corporate enterprises. Discussion includes: 1. Activities really compatible with the llfe insurance product. 2. Activities otherwise compatible with corporate objectives or offering potentially large profit centers. 3. Activities which can be an excessive drain on corporate earnings and executive manpower 4. The actuary's role in these diversification activities. Then the discussion goes into a discussion of corporate planning models

Description: "Minimum Social Security Benefit (s) and the Alone Stage of Retirement in the U.S.? – Lori J. Curtis, PhD., Douglas Andrews, FSA, FCIA, Ph.D., University of Waterloo The Importance of Cognitive Health – Gordon Woo,Ph.D., RMS LifeRisks"

Description: As the size of the life reinsurance market in Bermuda has grown to over half a trillion dollars at the end of 2021, more and more actuaries are getting involved with this 21 square mile North Atlantic island in one way or the other. Come explore a fundamental understanding of the Bermuda solvency framework and an overview of its upcoming changes.

Description: As the size of the life reinsurance market in Bermuda has grown to over half a trillion dollars at the end of 2021, more and more actuaries are getting involved with this 21 square mile North Atlantic island in one way or the other. Come explore a fundamental understanding of the Bermuda solvency framework and an overview of its upcoming changes.